Very early researchLooking for participantsNCT07387666What this trial is testingImaging Acetadote Metabolism in GlioblastomaWho this might be right forGlioblastomaGBM University of Texas Southwestern Medical Center 10
Early research (Phase 1)Ended earlyNCT07121829What this trial is testingTovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid TumorsWho this might be right forMelanomaSolid TumorPilocytic Astrocytoma+7 more Day One Biopharmaceuticals, Inc. 44
Very early researchStudy completedNCT00743353What this trial is testingExploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5Who this might be right forSarcomaMelanomaLung Cancer+2 more Siemens Molecular Imaging 16
Testing effectiveness (Phase 2)Looking for participantsNCT07326566What this trial is testingStudy of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIIWho this might be right forGlioblastoma (GBM)Newly Diagnosed GlioblastomaGBM+4 more Black Diamond Therapeutics, Inc. 162
Early research (Phase 1)Study completedNCT00694837What this trial is testingStudy With Nelfinavir and Combined Radiochemotherapy for GlioblastomaWho this might be right forGlioblastoma Maastricht Radiation Oncology 6
Early research (Phase 1)Study completedNCT01682187What this trial is testingA Dose-Escalation Study in Participants With Recurrent Malignant GliomaWho this might be right forGlioma Eli Lilly and Company 66
Early research (Phase 1)Looking for participantsNCT07076498What this trial is testingEngineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care RadiationWho this might be right forGlioma M.D. Anderson Cancer Center 20
Early research (Phase 1)Study completedNCT01222221What this trial is testingVaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors Cancer Research UK 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT03395587What this trial is testingEfficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed GlioblastomaWho this might be right forGlioblastoma Heinrich-Heine University, Duesseldorf 136
Not applicableUnknownNCT04122521What this trial is testingRadiogenomic and Prognosis Analysis in GliomaWho this might be right forGlioma Asan Medical Center 62
Early research (Phase 1)Study completedNCT00089427What this trial is testingIL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant GliomaWho this might be right forGlioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma INSYS Therapeutics Inc 24
Testing effectiveness (Phase 2)Study completedNCT04013672What this trial is testingStudy of Pembrolizumab Plus SurVaxM for Glioblastoma at First RecurrenceWho this might be right forRecurrent Glioblastoma David Peereboom 41
Not applicableActive Not RecruitingNCT03181477What this trial is testingStudy Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in GlioblastomasWho this might be right forGlioblastoma, Adult Centre Georges Francois Leclerc 67
Testing effectiveness (Phase 2)Ended earlyNCT01721577What this trial is testingPhase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant AstrocytomasWho this might be right forGlioblastomaGliosarcomaAnaplastic Astrocytoma+3 more Rush University Medical Center 10
Not applicableEnded earlyNCT02329795What this trial is testingImage-derived Prediction of Response to Chemo-radiation in GlioblastomaWho this might be right forGlioblastoma Rigshospitalet, Denmark 16
Testing effectiveness (Phase 2)Study completedNCT00079339What this trial is testingTipifarnib and Radiation Therapy in Treating Young Patients With Brainstem GliomaWho this might be right forUntreated Childhood Brain Stem Glioma National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)UnknownNCT05447195What this trial is testingPhase 2 Study of CAN008 in Subjects With GBMWho this might be right forNewly-diagnosed Glioblastoma CANbridge Life Sciences Ltd. 117
Testing effectiveness (Phase 2)Looking for participantsNCT07589257What this trial is testingVRT106 in Combination With Radiotherapy in Adult Patients With Diffuse Midline Glioma / Diffuse Intrinsic Pontine GliomaWho this might be right forDiffuse Midline Glioma, H3 K27M-MutantDiffuse Intrinsic Pontine Glioma Guangzhou Virotech Pharmaceutical Co., Ltd. 10
Large-scale testing (Phase 3)Ended earlyNCT03419403What this trial is testingUNITE Study: Understanding New Interventions With GBM ThErapyWho this might be right forGlioblastoma Multiforme AbbVie 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07758062What this trial is testingLevetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype GlioblastomaWho this might be right forGlioblastoma Tianjin Medical University General Hospital 140